Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis

被引：0
|
作者：
Azza AbuDagga
Judith J Stephenson
An-Chen Fu
Winghan Jacqueline Kwong
Hiangkiat Tan
William S Weintraub
机构：
[1] HealthCore,
[2] Inc.,undefined
[3] Daiichi Sankyo,undefined
[4] Inc.,undefined
[5] Christiana Care Health System,undefined
来源：
BMC Health Services Research | / 14卷
关键词：
Non-valvular atrial fibrillation; Dabigatran; Warfarin; Oral anticoagulation; Healthcare;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] DIRECT ORAL ANTICOAGULANT EDOXABAN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: RESULTS OF DIRECT COMPARISON WITH WARFARIN
    Yavelov, I. S.
    KARDIOLOGIYA, 2020, 60 (08) : 124 - 129
  • [42] Anticoagulation for non-valvular atrial fibrillation: new anticoagulant agents
    Kepez, Alper
    Erdogan, Okan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2013, 13 (04): : 379 - 384
  • [43] Safety of New Anticoagulant Treatments in Swedish Patients with Non-valvular Atrial Fibrillation
    Nyman, Anastasia
    Collin, Julius J. K. M.
    Borg, Natalia
    Gry, Marcus
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 405 - 405
  • [44] Geographic and Racial Variation in Oral Anticoagulant Treatment Among Commercially Insured Patients With Non-Valvular Atrial Fibrillation in the United States
    Atwater, Brett D.
    Singh, Risho
    Parmar, Shashi
    Ogbonnaya, Augustina
    Kang, Amiee
    Russ, Cristina
    Cheng, Dong
    Hagan, Melissa
    Deeba, Serina
    Hines, Dionne M.
    Atreja, Nipun
    CIRCULATION, 2023, 148
  • [45] ORAL AMIODARONE FOR THE NON-VALVULAR ATRIAL FIBRILLATION RECURRENCES: A RETROSPECTIVE COHORT STUDY
    De Vecchis, R.
    Paccone, A.
    Di Maio, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G142 - G142
  • [46] ORAL ANTICOAGULANT THERAPY AND RISK OF MACE IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: REAL WORLD EVIDENCE DATA.
    Armentaro, Giuseppe
    Condoleo, Valentino
    Divino, Marcello
    Pastura, Carlo Alberto
    Francica, Mattea
    Barbara, Keti
    Monaco, Vittoria
    Clausi, Elvira
    Scarcelli, Maria Rosangela
    Cuda, Patrizia
    Severini, Giandomenico
    De Marco, Mario
    Miceli, Sofia
    Maio, Raffaele
    Perticone, Maria
    Sciacqua, Angela
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [47] Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
    McHorney, Colleen A.
    Crivera, Concetta
    Laliberte, Francois
    Germain, Guillaume
    Wynant, Willy
    Lefebvre, Patrick
    PLOS ONE, 2018, 13 (04):
  • [48] Comparison of healthcare costs among patients with non-valvular atrial fibrillation treated with warfarin who switched to a novel oral anticoagulant
    Franchino-Elder, Jessica
    Gilligan, Adrienne
    Song, Xue
    Hartaigh, Briain O.
    Henriques, Caroline
    Sainski-Nguyen, Amy
    Wang, Cheng
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2020, 11 (02) : 133 - 140
  • [49] ORAL ANTICOAGULANT THERAPY AND DECLINE OF KIDNEY FUNCTION IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION:REAL WORLD EVIDENCE DATA
    Armentaro, Giuseppe
    Severini, Giandomenico
    Condoleo, Valentino
    Divino, Marcello
    Alberto Pastura, Carlo
    Francica, Mattea
    Barbara, Keti
    Monaco, Vittoria
    Clausi, Elvira
    Rosangela Scarcelli, Maria
    Cuda, Patrizia
    De Marco, Mario
    Miceli, Sofia
    Maio, Raffaele
    Perticone, Maria
    Sciacqua, Angela
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [50] DEVELOPMENT OF A MACHINE LEARNING PREDICTIVE MODEL FOR STROKE AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION RECEIVING ORAL ANTICOAGULANT TREATMENT
    Rebollo, P.
    Wolk, A.
    Luczko, M.
    Tang, J. P.
    VALUE IN HEALTH, 2022, 25 (12) : S374 - S374
12345